Lipoprotein(a) and coronary artery disease: Ongoing debate

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 18, Issue 7, 2008, Pages

  Celik, Turgay ^a   Yuksel, Cagdas ^b   Iyisoy, Atila ^a   Isik, Ersoy ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Sarikamis Army District Hospital Turkey   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BLOOD; CORONARY ARTERY DISEASE; HUMAN; LETTER; RISK ASSESSMENT; RISK FACTOR;

BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; HUMANS; LIPOPROTEIN(A); RISK ASSESSMENT; RISK FACTORS;

EID: 47949127806     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2008.01.005     Document Type: Letter

References (10)

1. Gaeta G., Cuomo S., Capozzi G., Foglia M.C., Barra S., Madrid A., et al. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction. Nutr Metab Cardiovasc Dis (2007 Oct 23) 10.1016/j.numecd.2007.03.006 [Epub ahead of print]
2. Utermann G. The mysteries of lipoprotein(a). Science 246 (1989) 904-910
3. Boerwinkle E., Leffert C.C., Lin J., Lackner C., Chiesa G., and Hobbs H.H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 90 (1992) 52-60
4. Bowden J.F., Pritchard P.H., Hill J.S., and Frohlich J.J. Lp(a) concentration and apo(a) isoform size. Relation to the presence of coronary artery disease in familial hypercholesterolemia. Arterioscler Thromb 14 (1994) 1561-1568
5. Rosenson R.S., and Stein J.H. Lp(a) metabolism and approach to the patient with high Lp(a) levels. In: Rose B.D. (Ed). UpToDate (2007), UpToDate, Wellesley
6. von Eckardstein A., Schulte H., Cullen P., and Assmann G. Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol 37 (2001) 434-439
7. Danesh J., Collins R., and Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 102 (2000) 1082-1085
8. Genest Jr. J.J., Martin-Munley S.S., McNamara J.R., Ordovas J.M., Jenner J., Myers R.H., et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85 (1992) 2025-2033
9. Tsimikas S., Brilakis E.S., Miller E.R., McConnell J.P., Lennon R.J., Kornman K.S., et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 353 (2005) 46-57
10. Superko H.R. Beyond LDL cholesterol reduction. Circulation 94 (1996) 2351-2354